Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
09/20/2024 | PUT | $66.00 | 2,008 | +1,412 | +236.91% |
11/15/2024 | CALL | $80.00 | 1,723 | +1,021 | +145.44% |
09/20/2024 | CALL | $71.00 | 1,714 | +924 | +116.96% |
09/27/2024 | PUT | $60.00 | 1,466 | +765 | +109.13% |
09/27/2024 | CALL | $70.00 | 1,522 | +661 | +76.77% |
10/18/2024 | PUT | $70.00 | 3,663 | +639 | +21.13% |
09/20/2024 | PUT | $90.00 | 127 | -546 | -81.13% |
09/20/2024 | PUT | $80.00 | 442 | -864 | -66.16% |
10/18/2024 | PUT | $100.00 | 332 | -1,088 | -76.62% |
01/17/2025 | PUT | $125.00 | 528 | -1,114 | -67.84% |
09/20/2024 | PUT | $75.00 | 279 | -1,437 | -83.74% |
01/17/2025 | PUT | $130.00 | 966 | -1,879 | -66.05% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 2.57% | 9.93M | 1.25B |
Vanguard International Growth Fund | 2.53% | 9.77M | 1.23B |
Vanguard 500 Index Fund | 1.98% | 7.64M | 961.76M |
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 5.08M | 639.64M |
Fidelity 500 Index Fund | 0.94% | 3.62M | 456.08M |
SPDR S&P 500 ETF Trust | 0.92% | 3.57M | 449.61M |
Vanguard Specialized-Health Care Fund | 0.90% | 3.49M | 439.87M |
Growth Fund Of America Inc | 0.80% | 3.11M | 391.58M |
iShares Core S&P 500 ETF | 0.76% | 2.95M | 371.32M |
Vanguard U.S. Growth Fund | 0.75% | 2.88M | 362.55M |
Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | DelveInsight
09/20 01:00 pm
GlobeNewswire Inc.
Read moreDown 13% in 1 Day, Is Moderna Stock in Trouble?
09/20 05:52 am
The Motley Fool
Read moreNovo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
09/19 06:50 am
The Motley Fool
Read moreModerna, Inc. REMINDER – MRNA Stockholders Should Contact Robbins LLP for Information About the Moderna, Inc. Class Action and Pending Lead Plaintiff Deadline
09/18 06:48 pm
GlobeNewswire Inc.
Read morePrediction: These Could Be the Best-Performing Biotech Stocks Through 2030
09/18 05:49 am
The Motley Fool
Read moreS&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers
09/17 04:37 pm
Benzinga
Read moreSmall Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday?
09/17 01:37 pm
Benzinga
Read moreMRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
09/16 04:00 pm
GlobeNewswire Inc.
Read moreModerna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
09/15 06:44 pm
Benzinga
Read moreDown More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
09/15 08:20 am
The Motley Fool
Read moreInvesting in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
09/14 09:15 am
The Motley Fool
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA
09/14 08:38 am
GlobeNewswire Inc.
Read moreModerna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target
09/13 06:34 pm
Benzinga
Read moreNCLA Suit Demands End to Gov’t Censorship of Support Groups for Victims of Covid Vaccine Injuries
09/13 01:55 pm
GlobeNewswire Inc.
Read moreShould You Buy Novavax Stock After This Regulatory Win?
09/13 07:50 am
The Motley Fool
Read moreA Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
09/13 07:30 am
The Motley Fool
Read moreModerna: Can the Strategic Focus Shift Revive Investor Confidence?
09/13 02:25 am
Investing.com
Read moreStocks Edge Up As Producer Inflation Supports Rate Cut Bets, Small Caps, Miners Rally: What's Driving Markets Thursday?
09/12 01:34 pm
Benzinga
Read moreGSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
09/11 12:13 pm
Benzinga
Read moreMRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
09/10 04:00 pm
GlobeNewswire Inc.
Read moreShould You Buy Stocks in September? Here's What History Says.
09/10 04:35 am
The Motley Fool
Read moreBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
09/09 09:00 pm
GlobeNewswire Inc.
Read moreWall Street Rallies After Last Week's Sell-Off, Palantir Soars On S&P 500 Inclusion, Airlines Rally: What's Driving Markets Monday?
09/09 01:35 pm
Benzinga
Read moreWhy Is Moderna Stock Trading Higher On Monday?
09/09 01:00 pm
Benzinga
Read moreIs It Time to Buy August's Worst-Performing Nasdaq Stocks?
09/07 04:31 am
The Motley Fool
Read moreModerna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
09/06 02:02 pm
Benzinga
Read moreCould This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?
09/05 10:00 am
The Motley Fool
Read moreMRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
09/04 04:00 pm
GlobeNewswire Inc.
Read moreMODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline
09/03 01:45 am
GlobeNewswire Inc.
Read moreMRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
08/29 04:00 pm
GlobeNewswire Inc.
Read moreModerna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
08/29 12:01 pm
Benzinga
Read more3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
08/27 09:45 am
The Motley Fool
Read moreBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm
08/26 09:00 pm
GlobeNewswire Inc.
Read moreROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA
08/24 04:27 pm
GlobeNewswire Inc.
Read moreWall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
08/24 11:20 am
The Motley Fool
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA
08/20 11:41 pm
GlobeNewswire Inc.
Read moreMNRA STOCK NEWS: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Moderna, Inc. Class Action
08/20 08:08 pm
GlobeNewswire Inc.
Read morePfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
08/19 04:07 am
The Motley Fool
Read moreROSEN, NATIONAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA
08/16 05:36 pm
GlobeNewswire Inc.
Read moreMRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08/14 12:50 pm
GlobeNewswire Inc.
Read moreROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MRNA
08/12 02:30 pm
GlobeNewswire Inc.
Read moreGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Moderna Inc. (MRNA)
08/12 01:55 pm
GlobeNewswire Inc.
Read moreBiogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised
08/01 12:25 pm
Zacks Investment Research
Read moreCheck Out What Whales Are Doing With MRNA - Benzinga
07/22 11:46 am
Benzinga
Read moreModerna director Afeyan sells over $1.8m in company stock By Investing.com - Investing.com Australia
07/19 07:34 pm
Investing.com
Read moreDecoding Moderna's Options Activity: What's the Big Picture? - Benzinga
07/19 10:34 am
Benzinga
Read moreMerck (MRK) Up 17% YTD on Keytruda Strength: Should You Buy? - Zacks Investment Research
07/16 11:00 am
Zacks Investment Research
Read more